Cargando…
Clinical outcomes in dogs with localized splenic histiocytic sarcoma treated with splenectomy with or without adjuvant chemotherapy
BACKGROUND: Localized splenic histiocytic sarcoma (HS) in dogs is a poorly understood disease, and could have longer survival times than disseminated or hemophagocytic HS. Understanding the clinical behavior of localized splenic HS can refine treatment recommendations. OBJECTIVE: To describe the cli...
Autores principales: | Latifi, Max, Tuohy, Joanne L., Coutermarsh‐Ott, Sheryl L., Klahn, Shawna L., Leeper, Haley, Dervisis, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694829/ https://www.ncbi.nlm.nih.gov/pubmed/32986268 http://dx.doi.org/10.1111/jvim.15910 |
Ejemplares similares
-
Risk Factors Associated with Development of Histiocytic Sarcoma in Bernese Mountain Dogs
por: Ruple, A., et al.
Publicado: (2016) -
Clinicopathological characteristics of histiocytic sarcoma affecting the central nervous system in dogs
por: Toyoda, Izumi, et al.
Publicado: (2020) -
High intensity focused ultrasound for the treatment of solid tumors: a pilot study in canine cancer patients
por: Carroll, Jennifer, et al.
Publicado: (2022) -
Histotripsy ablation for the treatment of feline injection site sarcomas: a first-in-cat in vivo feasibility study
por: Ruger, Lauren, et al.
Publicado: (2023) -
Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy
por: Faulhaber, Erica A., et al.
Publicado: (2021)